BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29446823)

  • 1. A confusing lesion of thyroid papillary carcinoma.
    Zehani A; Chelly I; Marrakchi J; Besbes G; Haouet S; Kchir N
    Tunis Med; 2017 Mar; 95(3):225-226. PubMed ID: 29446823
    [No Abstract]   [Full Text] [Related]  

  • 2. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
    Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
    Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Doppler ultrasonography of value for the differentiation between noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and invasive encapsulated follicular variant of papillary thyroid carcinoma?
    Rosario PW
    Clin Endocrinol (Oxf); 2018 Mar; 88(3):506-507. PubMed ID: 29178507
    [No Abstract]   [Full Text] [Related]  

  • 4. Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer.
    Ali SZ; Siperstein A; Sadow PM; Golding AC; Kennedy GC; Kloos RT; Ladenson PW
    Cancer Cytopathol; 2019 Jun; 127(6):362-369. PubMed ID: 31017745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features.
    Thompson LDR
    Ear Nose Throat J; 2021 Sep; 100(5_suppl):533S-535S. PubMed ID: 31760798
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
    Higuchi M; Hirokawa M; Kanematsu R; Tanaka A; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2018 Dec; 65(12):1193-1198. PubMed ID: 30282887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving concept of aggressive histological variants of differentiated thyroid cancer.
    Hernandez-Prera JC
    Semin Diagn Pathol; 2020 Sep; 37(5):228-233. PubMed ID: 32241577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the risk of an overdiagnosis of malignancy in the preoperative assessment of noninvasive follicular thyroid neoplasm with papillary-like nuclear features? A review of the cytology and ultrasonography of 12 cases.
    Ng Kee Kwong F; Fenlon C; van der Horst C
    Cytopathology; 2019 Jan; 30(1):122-124. PubMed ID: 30320951
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems in the diagnosis of thyroid papillary and follicular carcinoma].
    Xue WC; Hui YZ
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):220-3. PubMed ID: 17706110
    [No Abstract]   [Full Text] [Related]  

  • 10. The demise of follicular carcinoma of the thyroid gland.
    LiVolsi VA; Asa SL
    Thyroid; 1994; 4(2):233-6. PubMed ID: 7920009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
    Freitas BC; Cerutti JM
    Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid gland: international case conference.
    Kakudo K; Katoh R; Sakamoto A; Asa S; DeLellis RA; Carney JA; Naganuma H; Kameyama K; Takami H
    Endocr Pathol; 2002; 13(2):131-4. PubMed ID: 12165661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
    Jeon MJ; Song DE; Jung CK; Kim WG; Kwon H; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
    PLoS One; 2016; 11(12):e0167756. PubMed ID: 27936121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
    Teshima M; Tokita K; Ryo E; Matsumoto F; Kondo M; Ikegami Y; Shinomiya H; Otsuki N; Hiraoka N; Nibu KI; Yoshimoto S; Mori T
    BMC Cancer; 2019 Mar; 19(1):245. PubMed ID: 30885146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An International Interobserver Variability Reporting of the Nuclear Scoring Criteria to Diagnose Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: a Validation Study.
    Thompson LDR; Poller DN; Kakudo K; Burchette R; Nikiforov YE; Seethala RR
    Endocr Pathol; 2018 Sep; 29(3):242-249. PubMed ID: 29508145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
    Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
    Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group consensus review minimizes the diagnosis of "follicular lesion of undetermined significance" and improves cytohistologic concordance.
    Jing X; Knoepp SM; Roh MH; Hookim K; Placido J; Davenport R; Rasche R; Michael CW
    Diagn Cytopathol; 2012 Dec; 40(12):1037-42. PubMed ID: 21538963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
    Filetti S; Durante C; Hartl D; Leboulleux S; Locati LD; Newbold K; Papotti MG; Berruti A;
    Ann Oncol; 2019 Dec; 30(12):1856-1883. PubMed ID: 31549998
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytologic features of aggressive variants of follicular-derived thyroid carcinoma.
    Rossi ED; Faquin WC; Pantanowitz L
    Cancer Cytopathol; 2019 Jul; 127(7):432-446. PubMed ID: 31150164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coming to terms with NIFTP: A provisional approach for cytologists.
    Krane JF; Alexander EK; Cibas ES; Barletta JA
    Cancer Cytopathol; 2016 Nov; 124(11):767-772. PubMed ID: 27564464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.